Frederic Barbey

Rue Du Bugnon 46
Lausanne, VD 1011, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Myocardial fibrosis in the posterior myocardium in Fabry disease is associated with global rather than regional longitudinal strain reduction.

Myocardial fibrosis in the posterior myocardium in Fabry disease is associated with global rather than regional longitudinal strain reduction.

Journal: European heart journal. Cardiovascular Imaging

Published: October 20, 2024

Lysosphingolipid Quantitation in Plasma and Dried-Blood Spots Using Targeted High-Resolution Mass Spectrometry.

Lysosphingolipid Quantitation in Plasma and Dried-Blood Spots Using Targeted High-Resolution Mass Spectrometry.

Journal: Journal of clinical laboratory analysis

Published: September 02, 2024

Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.

Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.

Journal: European heart journal

Published: May 16, 2024

Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy.

Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy.

Journal: Heart (British Cardiac Society)

Published: February 06, 2024

Atypical cystic hepatorenal disease in a 40-year-old female: What is the diagnosis? A nephrology zebra.

Atypical cystic hepatorenal disease in a 40-year-old female: What is the diagnosis? A nephrology zebra.

Journal: Journal of nephrology

Published: May 25, 2023

Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease.

Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease.

Journal: Life (Basel, Switzerland)

Published: March 28, 2023

Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease.

Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: September 28, 2022

Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity.

Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity.

Journal: Molecular genetics and metabolism

Published: May 31, 2022

The use of 68Ga-EDTA PET allows detecting progressive decline of renal function in rats.

The use of 68Ga-EDTA PET allows detecting progressive decline of renal function in rats.

Journal: American journal of nuclear medicine and molecular imaging

Published: October 14, 2021

A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I.

A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I.

Journal: Molecular genetics and metabolism

Published: August 24, 2021

Isolated left ventricular hypertrophy : is it a Fabry disease?

Isolated left ventricular hypertrophy : is it a Fabry disease?

Journal: Revue medicale suisse

Published: October 07, 2020

Chaperone molecules: The example of Fabry disease

Chaperone molecules: The example of Fabry disease

Journal: Nephrologie & therapeutique

Published: January 24, 2020

Showing 1-12 of 38

Last Updated: 09/26/2026